Published in Regul Pept on August 13, 1993
Why isn't endogenous ouabain more widely accepted? Am J Physiol Heart Circ Physiol (2014) 2.10
Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats. Br J Pharmacol (1995) 0.77
Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat. Br J Pharmacol (1995) 0.75
[SAF--an alternative fixation solution for parasitological stool specimens]. Schweiz Med Wochenschr (1990) 1.34
Receptors for substance P. I. The pharmacological preparations. Eur J Pharmacol (1984) 1.24
The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization. Mol Pharmacol (1996) 1.21
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res (2002) 1.19
Role of N-glycosylation in the expression and functional properties of human AT1 receptor. Biochemistry (1999) 1.11
Visualization of neurokinin-3 receptor sites in rat brain using the highly selective ligand [3H]senktide. Brain Res (1990) 0.97
Analysis of the adrenal angiotensin II receptor with the photoaffinity labeling method. Biochemistry (1983) 0.96
Expression of the five somatostatin receptor (SSTR1-5) subtypes in rat pituitary somatotrophes: quantitative analysis by double-layer immunofluorescence confocal microscopy. Endocrinology (1997) 0.96
Caloxin: a novel plasma membrane Ca2+ pump inhibitor. Am J Physiol Cell Physiol (2001) 0.93
Adrenocorticotropin receptors in rat adrenal glomerulosa cells. Endocrinology (1985) 0.91
High yield photoaffinity labeling of angiotensin II receptors. Mol Pharmacol (1986) 0.91
Substance P antagonists active in vitro and in vivo. Eur J Pharmacol (1982) 0.90
Determination of peptide contact points in the human angiotensin II type I receptor (AT1) with photosensitive analogs of angiotensin II. Mol Endocrinol (1999) 0.89
Photolabeling identifies position 172 of the human AT(1) receptor as a ligand contact point: receptor-bound angiotensin II adopts an extended structure. Biochemistry (2000) 0.89
Undeca- and octa-peptide antagonists for substance P, a study on the guinea pig trachea. Eur J Pharmacol (1984) 0.88
Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype. J Biol Chem (1994) 0.87
The peptide encoded by angiotensin II complementary RNA does not interfere with angiotensin II action. Biochem J (1989) 0.87
Evidence for the existence of three classes of neurokinin receptors in brain. Differential ontogeny of neurokinin-1, neurokinin-2 and neurokinin-3 binding sites in rat cerebral cortex. Brain Res (1988) 0.86
Influence of surface properties at biodegradable microsphere surfaces: effects on plasma protein adsorption and phagocytosis. Pharm Res (1998) 0.86
Conformationally restricted C-terminal peptides of substance P. Synthesis, mass spectral analysis and pharmacological properties. J Med Chem (1985) 0.85
Functional effects of caloxin 1c2, a novel engineered selective inhibitor of plasma membrane Ca(2+)-pump isoform 4, on coronary artery. J Cell Mol Med (2008) 0.85
Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists. Eur J Pharmacol (1985) 0.85
Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa. Mol Pharmacol (1992) 0.85
Substance P--structure-activity studies and the development of antagonists. Pharmacology (1984) 0.85
Identification and characterization of a new growth hormone-releasing peptide receptor in the heart. Circ Res (1999) 0.85
The marked disparity between the sizes of angiotensin type 2 receptors from different tissues is related to different degrees of N-glycosylation. Mol Pharmacol (1994) 0.85
Neointima formation after vascular injury is angiotensin II mediated. Biochem Biophys Res Commun (1992) 0.85
Identification of angiotensin II-binding domains in the rat AT2 receptor with photolabile angiotensin analogs. J Biol Chem (1997) 0.84
Analysis of the role of N-glycosylation in cell-surface expression and binding properties of angiotensin II type-2 receptor of rat pheochromocytoma cells. Biochem J (1996) 0.84
p-Nitrophenylalanine, p-azidophenylalanine, m-azidophenylalanine, and o-nitro-p-azido-phenylalanine as photoaffinity labels. FEBS Lett (1974) 0.84
beta 2-Inhibin contains the active core of human seminal plasma beta-inhibin: synthesis and bioactivity. FEBS Lett (1985) 0.83
Identification of transmembrane domain residues determinant in the structure-function relationship of the human platelet-activating factor receptor by site-directed mutagenesis. J Biol Chem (1996) 0.83
Effects of a selective neutral endopeptidase and a nonselective neutral endopeptidase/endothelin-converting enzyme inhibitor on lipopolysaccharide-induced endotoxaemia in anaesthetized Sprague-Dawley rats. J Cardiovasc Pharmacol (2000) 0.83
Angiotensin-induced changes in the apparent size of rat liver angiotensin receptors. J Recept Res (1984) 0.82
Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue. Mol Pharmacol (1994) 0.82
Angiotensin II: dependence of hormone affinity on the electronegativity of a single side chain. J Med Chem (1984) 0.82
gamma-Preprotachykinin-(72-92)-peptide amide: an endogenous preprotachykinin I gene-derived peptide that preferentially binds to neurokinin-2 receptors. Proc Natl Acad Sci U S A (1990) 0.81
Epitope tagging and immunoreactivity of the human angiotensin II type 1 receptor. Can J Physiol Pharmacol (1997) 0.81
Receptors for substance P. III. Classification by competitive antagonists. Eur J Pharmacol (1984) 0.81
Improved activity of a new angiotensin receptor antagonist by an injectable spray-dried polymer microsphere preparation. Pharm Res (1997) 0.81
Inhibition of angiotensinogen production by angiotensin II analogues in human hepatoma cell line. Am J Physiol (1989) 0.81
Direct covalent attachment of small peptide antigens to enzyme-linked immunosorbent assay plates using radiation and carbodiimide activation. Anal Biochem (1994) 0.80
Substance P antagonists showing some selectivity for different receptor types. Eur J Pharmacol (1985) 0.80
The hydra head activator in human blood circulation. Degradation of the synthetic peptide by plasma angiotensin-converting enzyme. FEBS Lett (1984) 0.80
Photoaffinity labeling of subtype 2 angiotensin receptor of human myometrium. Mol Pharmacol (1993) 0.80
Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labeling. Endocrinology (1998) 0.79
An angiotensin II antagonist with strongly prolonged action. Biochem Biophys Res Commun (1989) 0.79
Anti-substance P anti-idiotypic antibodies. Characterization and biological activities. J Biol Chem (1985) 0.79
Partial agonists and antagonists for substance P. Eur J Pharmacol (1983) 0.79
Structure-activity studies on the C-terminal amide of substance P. J Med Chem (1982) 0.79
Angiotensin II is bound to both receptors AT1 and AT2, parallel to the transmembrane domains and in an extended form. Can J Physiol Pharmacol (2002) 0.78
Characterization of AT4 receptor from bovine aortic endothelium with photosensitive analogues of angiotensin IV. Biochemistry (1998) 0.78
Pharmacological properties of two analogues of angiotensin II containing carboranylalanine (Car). Eur J Pharmacol (1980) 0.78
Synthesis and biological activities of substance P antagonists. J Med Chem (1982) 0.78
Synthesis and immunological evaluation of N-terminal, noncrossreactive tachykinin antigens. J Med Chem (1988) 0.78
Angiotensin II analogues with sulphur-containing side-chains in position 5. A structure-activity relationship study. Arzneimittelforschung (2000) 0.78
Sar1-p-benzoylphenylalanine-angiotensin, a new photoaffinity probe for selective labeling of the type 2 angiotensin receptor. Regul Pept (1993) 0.78
Photoaffinity labelling of atrial natriuretic factor (ANF)-R1 receptor by underivatized 125I-ANF. Involvement of lipid peroxidation. Biochem J (1990) 0.78
Receptors for substance P. II. Classification by agonist fragments and homologues. Eur J Pharmacol (1984) 0.78
Molecular cloning of a ferret angiotensin II AT(1) receptor reveals the importance of position 163 for Losartan binding. Biochim Biophys Acta (2000) 0.77
Temperature-dependent variations of ligand-receptor contact points in hAT(1). J Pept Sci (2007) 0.77
N- and C-terminal structure-activity study of angiotensin II on the angiotensin AT2 receptor. Eur J Pharmacol (1998) 0.77
A novel procedure for daily measurements of hemodynamical, hematological, and biochemical parameters in conscious unrestrained rats. J Pharmacol Toxicol Methods (2001) 0.77
Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues. Eur J Pharmacol (1985) 0.77
Fluorescent peptide hormones: development of high affinity vasopressin analogues. Peptides (1992) 0.77
Pathomorphologic and microcirculatory changes and endothelin-1 expression in UW-and Celsior-preserved pancreata in experimental pancreas transplantation. Transplant Proc (2002) 0.77
Different populations of inositol 1,4,5-trisphosphate receptors expressed in the bovine adrenal cortex. Receptors Channels (2000) 0.76
Molecular weight determination of the hepatic vasopressin receptor with a high-affinity photoprobe. Int J Pept Protein Res (1996) 0.76
Essential role of leucine222 in mediating signal transduction of the human angiotensin II type 1 receptor. Receptors Channels (1998) 0.76
An angiotensin with prolonged action and blood pressure--lowering properties. J Cardiovasc Pharmacol (1990) 0.76
[The synthesis of 4'-azido-3',5'-ditritio-l-phenylalanine peptides as "photo-affinity probes" for ligand-receptor interaction (author's transl)]. Helv Chim Acta (1976) 0.76
Administration of a selective endothelin-a receptor antagonist (BSF 208075) improves hepatic warm ischemia/reperfusion injury in pigs. Transplant Proc (2002) 0.76
Use of LiCl in phospholipase C assays masks the impaired functionality of a mutant angiotensin II receptor. Cell Signal (1997) 0.76
Spinal actions of substance P analogues on cardiovascular responses in the rat: a structure-activity analysis. Can J Physiol Pharmacol (1987) 0.76
Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-monkeys. Prog Neuropsychopharmacol Biol Psychiatry (2000) 0.75
Highly efficient photoaffinity labeling of the hormone binding domain of atrial natriuretic factor receptor. Biochemistry (1992) 0.75
Effects of substance P analogues in the rat tail-flick test. Eur J Pharmacol (1987) 0.75
RXR acts as a coregulator in the regulation of genes of the hypothalamo-pituitary axis by thyroid hormone receptors. J Mol Endocrinol (2002) 0.75
Hydrodynamic properties of the angiotensin II receptor from bovine adrenal zona glomerulosa. Biochem J (1990) 0.75
A substance P antagonist not containing D-tryptophan. Eur J Pharmacol (1984) 0.75
Partial agonists and antagonists for substance P. Eur J Pharmacol (1984) 0.75
Studies on position 1 of angiotensin II: effects on affinity and duration of action from alkyl amide substitution. J Med Chem (1981) 0.75
The bradykinin B2 receptor couples less efficiently than the angiotensin AT1 receptor to the G protein Gq in transiently transfected COS-7 cells. Receptors Channels (1999) 0.75
Synthesis and biological activities of photoaffinity labeling analogues of substance P. J Med Chem (1982) 0.75
Study on the influence of tyrosine deprotonation on the myotropic action of angiotensin II. Can J Physiol Pharmacol (1979) 0.75
Paratrend sensor as a novel method for continuous monitoring of hepatic microperfusion. Transplant Proc (2002) 0.75
Attenuation of endothelin expression and histologic changes by administration of a selective endothelin-A receptor antagonist in pig pancreas transplantation. Transplant Proc (2002) 0.75
Low-energy (3-24 eV) electron damage to the peptide backbone. J Phys Chem B (2007) 0.75
Isolation and structure analysis of a photoproduct of the new photoaffinity label p-nitrophenylalanine. Helv Chim Acta (1977) 0.75
Biological activities of photoaffinity labeling analogues of kinins and their irreversible effects on kinin receptors. J Med Chem (1981) 0.75
Photoaffinity labeling of the angiotensin II receptor; pharmacology of the labeling peptides in the dark. Can J Physiol Pharmacol (1978) 0.75
[Searching for a long acting angiotensin II antagonist]. Union Med Can (1980) 0.75
Assays for radiolabel-photoaffinity labeling of Angiotensin receptors. Methods Mol Med (2001) 0.75
Temperature-induced ligand contact point variations of the hAT1 receptor and of the constitutively active mutant N111G-hAT1. Adv Exp Med Biol (2009) 0.75
Protective effect of a selective endothelin a receptor antagonist (BSF 208075) on graft pancreatitis in pig pancreas transplantation. Transplant Proc (2001) 0.75
Influence of a selective endothelin(A) receptor antagonist on the quantitative mRNA expression and the immunohistochemistry of vasoactive mediators after pancreas transplantation. Transplant Proc (2003) 0.75
The angiotensin II binding site on Mycoplasma hyorhynis is structurally distinct from mammalian AT1 and AT2 receptors. Regul Pept (1998) 0.75
Photoprobe peptides to map the interactions of angiotensin II with its receptor AT1. Adv Exp Med Biol (2009) 0.75
A new method of iodine labelling of peptide hormones. J Recept Res (1984) 0.75
In vitro study of frog (Rana ridibunda Pallas) interrenal function by use of a simplified perifusion system. VII. Lack of effect of somatostatin on angiotensin-induced corticosteroid production. Gen Comp Endocrinol (1984) 0.75